Article Details

PhaseBio Obtains $34M in Financing to Advance Therapies for PAH, Other Diseases

Retrieved on: 2018-09-06 21:41:15

Tags for this article:

Click the tags to see associated articles and topics

PhaseBio Obtains $34M in Financing to Advance Therapies for PAH, Other Diseases. View article details on hiswai:

Excerpt

<div>Hatteras Venture Partners, <b>New Enterprise Associates</b>, Syno Capital, AstraZeneca, Johnson & Johnson Innovation — JJDC, and Fletcher Spaght ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up